Company / Cash & Equivalents
ACHIEVE LIFE SCIENCES, INC. Cash & Equivalents History
FY2018-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$16.7M
FY2019
5-year range
$9.5M / $16.7M
FY2018-FY2019
Trend
+75.1%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$17M in FY2019.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, cash & equivalents increased 75.1% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.16 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $16.7M | +75.1% |
| FY2018 | $9.5M | - |
As of FY2019 · SEC 10-K · Updated Jun 21, 2026